Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCTH NASDAQ:NPCE NASDAQ:SGHT NASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$10.90-1.1%$11.41$8.08▼$18.23$385.49M0.85783,744 shs445,614 shsNPCENeuroPace$9.14-0.1%$9.33$5.45▼$18.98$302.70M1.9198,767 shs183,346 shsSGHTSight Sciences$3.87-4.7%$3.85$2.03▼$7.03$212.61M2.46116,645 shs60,961 shsSMLRSemler Scientific$29.37-0.9%$36.84$21.77▼$81.56$438.81M1.39529,760 shs602,968 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems-1.09%-1.98%+2.93%-33.46%-0.91%NPCENeuroPace-0.11%+1.90%+1.67%-30.60%+15.40%SGHTSight Sciences-4.68%-8.51%+18.35%-8.73%-42.84%SMLRSemler Scientific-0.91%-4.61%-14.77%-17.87%+10.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCTHDelcath Systems3.1647 of 5 stars3.51.00.00.03.72.51.3NPCENeuroPace3.8439 of 5 stars3.45.00.00.03.63.30.6SGHTSight Sciences2.7544 of 5 stars3.22.00.00.02.63.30.6SMLRSemler Scientific3.3459 of 5 stars3.64.00.00.02.01.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCTHDelcath Systems 3.00Buy$24.50124.77% UpsideNPCENeuroPace 2.83Moderate Buy$16.6081.62% UpsideSGHTSight Sciences 2.43Hold$4.4214.13% UpsideSMLRSemler Scientific 3.25Buy$81.75178.35% UpsideCurrent Analyst Ratings BreakdownLatest SGHT, DCTH, NPCE, and SMLR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025SGHTSight SciencesNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold8/21/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.60 ➝ $4.508/13/2025NPCENeuroPaceZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/13/2025NPCENeuroPaceWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$17.00 ➝ $15.008/8/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$3.00 ➝ $5.008/7/2025DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$29.00 ➝ $31.008/6/2025SMLRSemler ScientificCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$61.00 ➝ $60.007/28/2025SMLRSemler ScientificCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$61.007/28/2025SMLRSemler ScientificCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$61.007/15/2025SGHTSight SciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $4.007/9/2025SMLRSemler ScientificMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$95.00(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCTHDelcath Systems$37.21M10.25N/AN/A$3.00 per share3.63NPCENeuroPace$79.91M3.78N/AN/A$0.59 per share15.49SGHTSight Sciences$79.87M2.54N/AN/A$1.34 per share2.89SMLRSemler Scientific$56.29M7.73$4.44 per share6.62$25.90 per share1.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCTHDelcath Systems-$26.39M$0.05218.00N/AN/A3.18%6.91%5.80%11/14/2025 (Estimated)NPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/11/2025 (Estimated)SGHTSight Sciences-$51.51M-$0.96N/AN/AN/A-64.23%-59.38%-36.43%11/6/2025 (Estimated)SMLRSemler Scientific$40.90M$2.4312.09∞N/A86.20%43.84%32.88%11/3/2025 (Estimated)Latest SGHT, DCTH, NPCE, and SMLR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025NPCENeuroPace-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 million8/7/2025Q2 2025SGHTSight Sciences-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million8/6/2025Q2 2025DCTHDelcath Systems$0.02$0.07+$0.05$0.07$22.84 million$24.16 million8/4/2025Q2 2025SMLRSemler Scientific-$0.27$5.04+$5.31$5.04$8.10 million$8.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCTHDelcath SystemsN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCTHDelcath SystemsN/A10.889.87NPCENeuroPace3.025.474.51SGHTSight Sciences0.5710.019.49SMLRSemler Scientific0.250.600.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCTHDelcath Systems61.12%NPCENeuroPace78.83%SGHTSight Sciences55.51%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipDCTHDelcath Systems17.94%NPCENeuroPace20.50%SGHTSight Sciences28.90%SMLRSemler Scientific16.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCTHDelcath Systems6034.98 million28.71 millionOptionableNPCENeuroPace17033.08 million26.30 millionOptionableSGHTSight Sciences21052.37 million37.23 millionOptionableSMLRSemler Scientific12014.81 million12.38 millionNot OptionableSGHT, DCTH, NPCE, and SMLR HeadlinesRecent News About These CompaniesSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm2 hours ago | prnewswire.com27,351 Shares in Semler Scientific Inc. $SMLR Purchased by Nuveen LLC3 hours ago | marketbeat.comSMLR Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Semler Scientific, Inc. Class Action LawsuitSeptember 2 at 6:00 PM | globenewswire.comROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLRSeptember 2 at 2:48 PM | globenewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler ScientificSeptember 2 at 1:23 PM | businesswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc. (SMLR)September 2 at 12:40 PM | globenewswire.comSMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 2 at 12:00 PM | globenewswire.comINVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Semler Scientific, Inc. (SMLR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmSeptember 2 at 10:30 AM | globenewswire.comSemler Scientific Inc. $SMLR Shares Acquired by Charles Schwab Investment Management Inc.August 30, 2025 | marketbeat.comSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law FirmAugust 29, 2025 | prnewswire.comInvestor Alert: Robbins LLP Informs Investors that a Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc.August 29, 2025 | prnewswire.comSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 29, 2025 | businesswire.comSemler Scientific, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; October 28, 2025 Deadline to file Lead Plaintiff MotionAugust 29, 2025 | globenewswire.comEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors - SMLRAugust 29, 2025 | tmcnet.comEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors – SMLRAugust 29, 2025 | businesswire.comTruvestments Capital LLC Grows Holdings in Semler Scientific Inc. $SMLRAugust 29, 2025 | marketbeat.comCapital Fund Management S.A. Invests $1.10 Million in Semler Scientific Inc. $SMLRAugust 28, 2025 | marketbeat.comWitnessing An Insider Decision, Douglas Murphy-Chutorian Exercises Options Valued At $1.68M At Semler ScientificAugust 27, 2025 | benzinga.comCrypto treasury myth: Investors are misunderstanding $150 billion marketAugust 27, 2025 | msn.comKovitz Investment Group Partners LLC Has $378,000 Stock Holdings in Semler Scientific Inc. $SMLRAugust 24, 2025 | marketbeat.comLPL Financial LLC Decreases Position in Semler Scientific Inc. (NASDAQ:SMLR)August 18, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSGHT, DCTH, NPCE, and SMLR Company DescriptionsDelcath Systems NASDAQ:DCTH$10.90 -0.12 (-1.09%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$11.06 +0.16 (+1.50%) As of 05:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.NeuroPace NASDAQ:NPCE$9.14 -0.01 (-0.11%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$9.22 +0.08 (+0.83%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Sight Sciences NASDAQ:SGHT$3.87 -0.19 (-4.68%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$3.87 0.00 (0.00%) As of 09/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.Semler Scientific NASDAQ:SMLR$29.37 -0.27 (-0.91%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$29.82 +0.45 (+1.55%) As of 06:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CrowdStrike Tests $412 Support as Options Traders Turn Bullish Loop Industries Insiders Buy Stock, Signal Confidence in Outlook Joby Aviation's Pullback: A Gift for Investors Who See the Future Kohl’s Stock Rebound Faces a Showdown With Short Sellers Amazon Faces Rare Downgrade—Is the Rally at Risk? What to Watch for From D-Wave Now That Earnings Are Done Alibaba Rallies on New AI Chip Design, Sending NVIDIA Stock Lower 3 High-Yield Stocks Just Supercharged Their Dividends Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
